As smartphone-based diagnostics pick up steam within the industry, researchers are harnessing the technology to develop an automated device that uses video to pinpoint parasitic worms from a single drop of blood, potentially cutting down on infectious diseases in Africa.
The Department of Homeland Security warned that due to a cybersecurity flaw, a low-skilled remote hacker could alter the configurations of Hospira's LifeCare PCA Infusion System.
Another sign of the growing interesting in neurotechnology is a spike in the number of patents awarded in the arena, from about 300 a year to 1,600 last year.
Gemany's Siemens promised 4,500 additional layoffs on the heels of its original goal to reduce headcount by about 7,500 employees, pushing the total number of jobless or soon-to-be-jobless employees well past 10,000.
Johnson & Johnson's DePuy Synthes CMF, a unit of the business focused on surgical products for the head, neck and thorax, has launched Synthecel, the first marketed dural replacement made of cellulose for use in brain surgery.
The world's smallest cardiac monitor implant is on track to make a move into the doctor's office. Medtronic's aim is to further capitalize upon a hugely successful launch of its Reveal Linq that's already exceeded all expectations with a potential for drug-like blockbuster annual sales of $1 billion to $2 billion.
With the acquisition of two medical software programs from Andover, MA's S2 Interactive, Smith & Nephew is throwing more chips on the table when it comes to its disruptive, rep-less sales pilot program.
Ceterix Orthopaedics reeled in $35 million to bolster development of its arthroscopic surgical tools as it strives to bring its meniscal repair device to market.
Moximed anticipates that its KineSpring System will prove useful for osteoarthritis sufferers as a first surgical step offered before arthroplasty. In support of its quest, the company has raised $33 million that it expects will be sufficient to gain FDA approval for the system.
FDA issues warning letter to Smith & Nephew regarding questionable operations at plant in Andover, MA
The FDA slapped Smith & Nephew with a warning letter for quality-control violations at its Andover, MA, facility related to problems with some of the company's mechanical morcellators for removal of intrauterine tissue. The company has placed a hold on shipments of its Truclear Ultra Reciprocating Morcellator 4.0 while it further investigates customer complaints.
Privately held Welch Allyn continued its acquisition spree with its fourth buyout since June 2014, this time of White Plains, NY's Scale-Tronix, a manufacturer of medical scales.
Venture-backed startup Transcend Medical is expecting to submit a PMA for its novel minimally invasive glaucoma surgical implant during the next half of the year. The move comes after the company garnered positive pivotal data, which it has just released.
Life sciences venture capital firm RiverVest Venture Partners announced the creation of the $80 million RiverVest Venture Fund III at $80.2 million.
Eli Lilly will open a new drug delivery and device innovation center in Cambridge, MA. Medical devices aren't a focus for the pharma now--but it noted that more than half of its current pipeline candidates are biologics that require injection. It expects to double its revenues from device-enabled products by 2020 and is looking to have a hand in that arena.
Controversial genetic testing company 23andMe is finding new ways to stay relevant after the FDA yanked its popular--and once lucrative--direct-to-consumer diagnostic from the market in 2013.
Gastrointestinal endoscopy player EndoChoice has filed with the SEC for a big IPO that's long been rumored to raise up to $115 million. Med tech players have been facing a mixed bag on Wall Street this year, as an uncommon number are making it onto the market but most have faced weak short-term returns. In addition, several med techs have been forced to withdraw proposed offerings as investor demand remains selective.
IBM is rolling out at an enhanced, cancer-fighting version of its Jeopardy-winning supercomputer Watson at more than a dozen hospitals across the U.S. The move demonstrates the advent of Big Data, cognitive technology and personalized medicine in healthcare.
As the industry and regulators respond to public outcry over power morcellators used in minimally invasive gynecological procedures, one of the U.S.'s largest health insurers is curtailing its coverage of the device.
The FDA released the documents of its May 14-15 meeting about the duodenoscope safety scare, which has been implicated in a few recent deaths of patients who picked up the drug-resistant bacteria CRE due to improper sterilization.
Minimally invasive spinal surgery specialist NuVasive announced the launch of its Integrated Global Alignment platform at the American Association of Neurological Surgeons' annual meeting in Washington, DC.